AHA 2010 schedule: Difference between revisions

Jump to navigation Jump to search
 
(28 intermediate revisions by the same user not shown)
Line 20: Line 20:
==Saturday November 13, 2010==
==Saturday November 13, 2010==


===3:30 PM===
===1:15 PM===
''3:30 PM - 4:00 PM''
''1:15 PM - 1:45 PM''
*'''Interviewee:''' Dr. Adrian F. Hernandez and Dr. Christopher M. O'Connor
*'''Interviewee:''' Dr. Adrian F. Hernandez and Dr. Christopher M. O'Connor and Dr. Randy Starling
*'''Trial:''' Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
*'''Trial:''' Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
*'''Embargo lift:''' 5:23 PM on Sunday November 14, 2010  
*'''Embargo lift:''' 5:23 PM on Sunday November 14, 2010  


===4:00 PM===
===1:45 PM===
''4:00 PM - 4:30 PM''
''1:45 PM - 2:15 PM''
*'''Interviewee:''' Dr. Christopher M. O'Connor and Dr. Robert Harrington
*'''Interviewee:''' Dr. Clyde Yancy
*'''Topic:''' Duke's Presence at AHA, What's Happening, What to Expect Segment 1
*'''Topic:''' ASCEND:  Historical perspective, implications for patients
 
===3:15 PM===
''3:15 PM - 3:45 PM''
*'''Interviewee:''' Dr. Manesh Patel and Dr. Ken Mahaffey and Dr. Keith Fox
*'''Trial:''' : Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)
*'''Embargo lift:''' 10:55 AM Monday November 15, 2010
 
===3:45 PM===
''3:45 PM - 4:15 PM''
*'''Interviewee:''' Dr. Zubin Eapen
*'''Topic:''' AHA 2010: A Cardiology Fellow's Perspective


===4:30 PM===
===4:30 PM===
''4:30 PM - 5:00 PM''
''4:30 PM - 5:00 PM''
*'''Interviewee:''' Dr. Christopher M. O'Connor and Dr. Robert Harrington  
*'''Interviewee:''' Dr. Christopher M. O'Connor and Dr. Robert Harrington  
*'''Topic:''' Duke's Presence at AHA, What's Happening, What to Expect Segment 2
*'''Topic:''' Duke's Presence at AHA, What's Happening, What to Expect


===5:00 PM===
===5:00 PM===
Line 41: Line 52:
===5:30 PM===
===5:30 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>
===6:00 PM===
''6:00 PM - 6:30 PM''
*'''Interviewee:''' Mona Fiuzat
*'''Topic:''' Analysis about trends in the Stock Market and ACS


==Sunday November 14, 2010==
==Sunday November 14, 2010==
Line 56: Line 62:


===1:30 PM===
===1:30 PM===
<font color=red>OPEN TIME SLOT</font>
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Dr. Kenneth Ellenbogen
*'''Trial:''' Primary Results from the ADVANCE Bridge to Transplant Trial Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)
*'''Embargo lift:''' 4:39 PM Monday November 15, 2010


===2:00 PM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
''2:00 PM - 2:30 PM''
*'''Interviewee:''' Dr. David Cohen
*'''Trial:''' Health-Related Quality of Life After Transcatheter Aortic Valve Implantation vs. Non-Surgical Therapy Among Inoperable Patients With Severe Aortic Stenosis: Results From the Randomized PARTNER Trial (Cohort B)
*'''Embargo lift:''' 4:55 PM on Monday November 15, 2010


===2:30 PM===
===2:30 PM===
<font color=red>OPEN TIME SLOT</font>
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Dr. Jonathan Piccini
*'''Trial:''' Sustained Ventricular Tachycardia and Ventricular Fibrillation Are Infrequent Events but are Associated with Increased Arrhythmic and All-Cause Death Following Non-ST-Segment Elevation Acute Coronary Syndromes
*'''Embargo lift:''' 12:00 PM on Wednesday November 17, 2010


===3:00 PM===
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
''3:00 PM - 3:30 PM''
*'''Interviewee:''' Dr. Thomas Povsic
*'''Trial:''' RB006, a Direct Factor IX Inhibitor Results in Consistent and Near Complete Inhibition of Factor IX in Patients with Acute Coronary Syndromes: A RADAR Pharmacokinetic and Pharmacodynamic Substudy
*'''Embargo lift:''' 11:00 AM on Tuesday November 16, 2010


===3:30 PM===
===3:30 PM===
Line 71: Line 89:


===4:00 PM===
===4:00 PM===
<font color=red>OPEN TIME SLOT</font>
''4:00 PM - 4:30 PM''
*'''Interviewee:''' Dr. Karen Alexander
*'''Trial:''' 1. The Coming Tsunami: Cardiovascular Disease in the Elderly 2. Frail Older Adults at Risk for Loss of Independence following MI
*'''Embargo lift:''' 1. 5:45 PM Monday November 15, 2010 2. 11:00 AM on Monday November 15, 2010


===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
''4:30 PM - 5:00 PM''
*'''Interviewee:''' Dr. Renato Lopes
*'''Topic:''' The Process of Building a Small Data Coordinating Center


===5:00 PM===
===5:00 PM===
Line 99: Line 122:


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Kristin Newby
*'''Topics:''' 1. MURDOCK Study Progress and Substudies 2. Biomarkers:  Challenges and Opportunities


===10:30 AM===
===10:30 AM===
Line 126: Line 151:


===4:00 PM===
===4:00 PM===
<font color=red>OPEN TIME SLOT</font>
''4:00 PM - 4:30 PM''
*'''Interviewee:''' Dr. Matthew Price
*'''Trial:''' Standard Versus High-Dose Clopidogrel According to Platelet Function Testing After PCI: Results of the GRAVITAS Trial
*'''Embargo lift:''' 10:55 AM on Tuesday November 16, 2010


===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
''4:30 PM - 5:00 PM''
*'''Interviewee:''' Dr. James Daubert
*'''Trial:''' QTc Prolongation During Therapeutic Hypothermia: Does It Deserve Attention?
*'''Embargo lift:''' 6:45 PM on Saturday November 13, 2010
 


===5:00 PM===
===5:00 PM===
<font color=red>OPEN TIME SLOT</font>                                                                                                             
''5:00 PM - 5:30 PM''
*'''Interviewee:''' Dr. Renato Lopes
*'''Topic:''' AHA wrap-up (Portuguese)
                                                                                                         


''[[AHA 2010 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[AHA 2010 schedule#Click on Date for Detailed Schedule|Return to top]]''


==Tuesday November 16, 2010==
==Tuesday November 16, 2010==
===8:00 AM===
''8:00 AM - 8:30 AM''
*'''Interviewee:''' Dr. Manesh Patel and Dr. Ken Mahaffey
*'''Trial:''' : Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)
*'''Embargo lift:''' 10:55 AM Monday November 15, 2010


===9:00 AM===
===9:00 AM===
Line 151: Line 180:


===9:30 AM===
===9:30 AM===
<font color=red>OPEN TIME SLOT</font>
''9:30 AM - 10:00 AM''
*'''Interviewee:''' Dr. Stephen J. Nicholls
*'''Trial:''' : Results of the First Major Clinical Trial of An Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CV Risk Modification
*'''Embargo lift:''' 11:39 AM on Wednesday November 17, 2010


===10:00 AM===
===10:00 AM===
''10:00 AM - 10:30 AM''
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Richard A. Becker  
*'''Interviewee:''' Dr. Richard A. Becker  
*'''Trial:''' : RB006, a Direct Factor IX Inhibitor Results in Consistent and Near Complete Inhibition of Factor IX in Patients with Acute Coronary Syndromes – A RADAR Pharmacokinetic and Pharmacodynamic Substudy
*'''Topic:''' : Pathways in Anticoagulation: what's most efficacious, safest.
*'''Embargo lift:''' 11:00 AM Tuesday November 16, 2010


===10:30 AM===
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
''10:30 AM - 11:00 AM''
*'''Interviewee:''' Dr. William Weintraub
*'''Topic:''' : Top 100 Vocabulary Project


===11:00 AM===
===11:00 AM===
''11:00 AM - 11:30 AM''
''11:00 AM - 11:30 AM''
*'''Interviewee:''' Dr. Christopher Granger
*'''Interviewee:''' Dr. Christopher Granger and Mayme Roettig, RN
*'''Trial:''' State-Wide Care is Imporved in the Reperfusion of Acute MI in Carolina Emergency Department Emergency Response (RACE-ER) Systems Imporvement Program: Preliminary Results  
*'''Trial:''' 1. State-Wide Care is Imporved in the Reperfusion of Acute MI in Carolina Emergency Department Emergency Response (RACE-ER) Systems Imporvement Program: Preliminary Results  
2. Mission Lifeline Update:  2010
*'''Embargo lift:''' 10:15 AM on Tuesday November 16, 2010
*'''Embargo lift:''' 10:15 AM on Tuesday November 16, 2010


===1:00 PM===
===1:00 PM===
''1:00 PM - 1:30 PM''
''1:00 PM - 1:30 PM''
*'''Interviewee:''' Jennifer Li
*'''Interviewee:''' Dr. Jennifer Li
*'''Trial:''' : Lessons from Pediatric Cardiovascular Drug Trials.  
*'''Trial:''' : Lessons from Pediatric Cardiovascular Drug Trials.  
*'''Embargo lift:''' 8:20 AM on Sunday November 14, 2010
*'''Embargo lift:''' 8:20 AM on Sunday November 14, 2010
Line 193: Line 227:


===3:00 PM===
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
''3:00 PM - 3:30 PM''
*'''Interviewee:''' Dr. Magnus Ohman
*'''Topics:''' 1. TRILOGY:  an update 2. LVADs:  improving outcomes
 


===3:30 PM===
===3:30 PM===
Line 236: Line 273:


===11:30 AM===
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
''11:30 AM - 12:00 PM''
*'''Interviewee:''' Dr. Matthew Brennan
*'''Trial:''' 1. Predictors of Bioprosthetic Aortic Valve Failure: Results in 73,616 Patients from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery National Database 2. Contemporary Risk of Follow-up Adverse Events in Older Patients with Chronic Kidney Disease and Dialysis Undergoing Percutaneous Coronary Interventions: A Report from the Merged NCDR CMS Registry
*'''Embargo:''' 1.5:00 PM on Wednesday November 17, 2010 2. 5:00 PM on Monday November 15, 2010
 


===12:00 PM===
===12:00 PM===
Line 242: Line 283:


===12:30 PM===
===12:30 PM===
<font color=red>OPEN TIME SLOT</font>
''12:30 PM - 1:00 PM''
*'''Interviewee:''' Dr. Robert Harrington
*'''Topic:''' Duke Day in Review


''[[AHA 2010 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[AHA 2010 schedule#Click on Date for Detailed Schedule|Return to top]]''

Latest revision as of 14:06, 11 November 2010

Here is the page we will use to coordinate the TV events at AHA 2010. Open time slots are indicated below in red. Filming Location: TBA



Click on Date for Detailed Schedule

Saturday November 13, 2010

Sunday November 14, 2010

Monday November 15, 2010

Tuesday November 16, 2010

Wednesday November 17, 2010


Saturday November 13, 2010

1:15 PM

1:15 PM - 1:45 PM

  • Interviewee: Dr. Adrian F. Hernandez and Dr. Christopher M. O'Connor and Dr. Randy Starling
  • Trial: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
  • Embargo lift: 5:23 PM on Sunday November 14, 2010

1:45 PM

1:45 PM - 2:15 PM

  • Interviewee: Dr. Clyde Yancy
  • Topic: ASCEND: Historical perspective, implications for patients

3:15 PM

3:15 PM - 3:45 PM

  • Interviewee: Dr. Manesh Patel and Dr. Ken Mahaffey and Dr. Keith Fox
  • Trial: : Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)
  • Embargo lift: 10:55 AM Monday November 15, 2010

3:45 PM

3:45 PM - 4:15 PM

  • Interviewee: Dr. Zubin Eapen
  • Topic: AHA 2010: A Cardiology Fellow's Perspective

4:30 PM

4:30 PM - 5:00 PM

  • Interviewee: Dr. Christopher M. O'Connor and Dr. Robert Harrington
  • Topic: Duke's Presence at AHA, What's Happening, What to Expect

5:00 PM

OPEN TIME SLOT

5:30 PM

OPEN TIME SLOT

Sunday November 14, 2010

1:00 PM

1:00 PM - 1:30 PM

  • Interviewee: Dr. Deepak Voora
  • Trial: A Whole Blood RNA Signature Accurately Classifies Multiple Measures of Platelet Function on Aspirin in Healthy Volunteers and Highlights a Common Underlying Pathway
  • Embargo lift: 3:15 PM Monday November 15, 2010

1:30 PM

1:30 PM - 2:00 PM

  • Interviewee: Dr. Kenneth Ellenbogen
  • Trial: Primary Results from the ADVANCE Bridge to Transplant Trial Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)
  • Embargo lift: 4:39 PM Monday November 15, 2010

2:00 PM

2:00 PM - 2:30 PM

  • Interviewee: Dr. David Cohen
  • Trial: Health-Related Quality of Life After Transcatheter Aortic Valve Implantation vs. Non-Surgical Therapy Among Inoperable Patients With Severe Aortic Stenosis: Results From the Randomized PARTNER Trial (Cohort B)
  • Embargo lift: 4:55 PM on Monday November 15, 2010

2:30 PM

2:30 PM - 3:00 PM

  • Interviewee: Dr. Jonathan Piccini
  • Trial: Sustained Ventricular Tachycardia and Ventricular Fibrillation Are Infrequent Events but are Associated with Increased Arrhythmic and All-Cause Death Following Non-ST-Segment Elevation Acute Coronary Syndromes
  • Embargo lift: 12:00 PM on Wednesday November 17, 2010

3:00 PM

3:00 PM - 3:30 PM

  • Interviewee: Dr. Thomas Povsic
  • Trial: RB006, a Direct Factor IX Inhibitor Results in Consistent and Near Complete Inhibition of Factor IX in Patients with Acute Coronary Syndromes: A RADAR Pharmacokinetic and Pharmacodynamic Substudy
  • Embargo lift: 11:00 AM on Tuesday November 16, 2010

3:30 PM

OPEN TIME SLOT

4:00 PM

4:00 PM - 4:30 PM

  • Interviewee: Dr. Karen Alexander
  • Trial: 1. The Coming Tsunami: Cardiovascular Disease in the Elderly 2. Frail Older Adults at Risk for Loss of Independence following MI
  • Embargo lift: 1. 5:45 PM Monday November 15, 2010 2. 11:00 AM on Monday November 15, 2010

4:30 PM

4:30 PM - 5:00 PM

  • Interviewee: Dr. Renato Lopes
  • Topic: The Process of Building a Small Data Coordinating Center

5:00 PM

5:00 PM - 5:30 PM

  • Interviewee: Dr. Tracy Wang
  • Trial: Under-Utilization of Emergency Medical Service Transport Among Contemporary Patients with ST-Elevation Myocardial Infarction – Findings from the National Cardiovascular Data Registry ACTION, Get with the Guidelines
  • Embargo lift: 4:08 PM Tuesday November 16, 2010

Return to top

Monday November 15, 2010

9:00 AM

9:00 AM - 9:30 AM

  • Interviewee: Dr. Christoph Kaiser
  • Trial: Late Cardiac Death And Myocardial Infarction Associated With Late Stent Thrombosis In Large Vessel Stenting After 1st Or 2nd Generation Drug-eluting Compared To Bare-metal Stents: the BASKET PROspective Evaluation Examination (BASKET PROVE)
  • Embargo lift: 11:39 AM Tuesday November 16, 2010

9:30 AM

9:30 AM - 10:00 AM

  • Interviewee: Karen S. Pieper
  • Trial: Proton Pump Inhibitor Use Is Likely a Marker for, Rather than a Cause of, a Higher Risk of Cardiovascular Events – Insights from PLATO
  • Embargo lift: 9:15 AM Tuesday November 16, 2010

10:00 AM

10:00 AM - 10:30 AM

  • Interviewee: Dr. Kristin Newby
  • Topics: 1. MURDOCK Study Progress and Substudies 2. Biomarkers: Challenges and Opportunities

10:30 AM

10:30 AM - 11:00 AM

  • Interviewee: Prof. Murray Esler
  • Trial: Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial Of Endovascular Selective Renal Sympathetic Denervation For The Treatment Of Hypertension
  • Embargo lift: 12:01 PM on Wednesday November 16, 2010

11:00 AM

11:00 AM - 11:30 AM

  • Interviewee: Dr. Otavio Berwanger
  • Trial: Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography
  • Embargo lift: 12:01 PM Tuesday November 16, 2010

3:00 PM

3:00 PM - 3:30 PM

  • Interviewee: Dr. Anthony Furlan
  • Trial: CLOSURE I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients with a Stroke or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale
  • Embargo lift: 12:01 PM Monday November 15, 2010

3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Dr. Keith Aaronson
  • Trial: Evaluation of the HeartWare® HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge to Transplant Trial.
  • Embargo lift: 4:17 PM Sunday November 14, 2010

4:00 PM

4:00 PM - 4:30 PM

  • Interviewee: Dr. Matthew Price
  • Trial: Standard Versus High-Dose Clopidogrel According to Platelet Function Testing After PCI: Results of the GRAVITAS Trial
  • Embargo lift: 10:55 AM on Tuesday November 16, 2010

4:30 PM

4:30 PM - 5:00 PM

  • Interviewee: Dr. James Daubert
  • Trial: QTc Prolongation During Therapeutic Hypothermia: Does It Deserve Attention?
  • Embargo lift: 6:45 PM on Saturday November 13, 2010


5:00 PM

5:00 PM - 5:30 PM

  • Interviewee: Dr. Renato Lopes
  • Topic: AHA wrap-up (Portuguese)


Return to top

Tuesday November 16, 2010

9:00 AM

9:00 AM - 9:30 AM

  • Interviewee: Dr. Sunil Rao
  • Trial: : A Randomized Placebo Controlled Trial of Intravenous Erythropoietin to Reduce Infarct Size After ST-Segment Elevation Myocardial Infarction – Primary Results of the REVEAL Trial
  • Embargo lift: 4:10 PM Monday November 15, 2010

9:30 AM

9:30 AM - 10:00 AM

  • Interviewee: Dr. Stephen J. Nicholls
  • Trial: : Results of the First Major Clinical Trial of An Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CV Risk Modification
  • Embargo lift: 11:39 AM on Wednesday November 17, 2010

10:00 AM

10:00 AM - 10:30 AM

  • Interviewee: Dr. Richard A. Becker
  • Topic: : Pathways in Anticoagulation: what's most efficacious, safest.

10:30 AM

10:30 AM - 11:00 AM

  • Interviewee: Dr. William Weintraub
  • Topic: : Top 100 Vocabulary Project

11:00 AM

11:00 AM - 11:30 AM

  • Interviewee: Dr. Christopher Granger and Mayme Roettig, RN
  • Trial: 1. State-Wide Care is Imporved in the Reperfusion of Acute MI in Carolina Emergency Department Emergency Response (RACE-ER) Systems Imporvement Program: Preliminary Results

2. Mission Lifeline Update: 2010

  • Embargo lift: 10:15 AM on Tuesday November 16, 2010

1:00 PM

1:00 PM - 1:30 PM

  • Interviewee: Dr. Jennifer Li
  • Trial: : Lessons from Pediatric Cardiovascular Drug Trials.
  • Embargo lift: 8:20 AM on Sunday November 14, 2010

1:30 PM

1:30 PM - 2:00 PM

  • Interviewee: Dr. Sara Pasquali
  • Trial: : Patient, Operative, and Center Factors Impacting Post-operative Outcomes in Patients Undergoing the Fontan Operation: Analysis of a National Clinical Database and; The Impact of Intensive Care Unit Structure on Post-operative Outcomes Following Congenital Heart Surgery: Analysis of a Multi-institutional Database
  • Embargo lift: 4:30 PM on Tuesday November 16, 2010 and 12 PM on Monday November 15, 2010.

2:00 PM

2:00 PM - 2:30 PM

  • Interviewee: Dr. Christopher P. Cannon
  • Trial: Primary Results of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
  • Embargo lift: 11:17 AM on Wednesday November 17, 2010

2:30 PM

2:30 PM - 3:00 PM

  • Interviewee: Dr. Robert A. Harrington
  • Trial: Beyond 2010. The Future of Antithrombic Therapy – Old Agent Replacement, Combination Therapy, and the Impact of Generics
  • Embargo lift: 5:00 PM on Tuesday November 16, 2010

3:00 PM

3:00 PM - 3:30 PM

  • Interviewee: Dr. Magnus Ohman
  • Topics: 1. TRILOGY: an update 2. LVADs: improving outcomes


3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Dr. Peter R. Kowey
  • Trial: Efficacy And Safety Of Prescription Omega-3-Acid Ethyl Esters (P-OM3) For The Prevention Of Recurrent Symptomatic Atrial Fibrillation (AF)
  • Embargo lift: 11:39 AM Monday November 15, 2010

4:00 PM

OPEN TIME SLOT

4:30 PM

4:30 PM - 5:00 PM

  • Interviewee: Dr. Zubin Eapen
  • Trial: Do Heart Failure Disease Management Programs Make Financial Sense Under a Bundled Payment System?
  • Embargo lift: 2:45 PM Tuesday November 16, 2010

5:00 PM

5:00 PM - 5:30 PM

  • Interviewee: Dr. Sergio Leonardi
  • Trial: Lack of Implementation of ESC/ACC Definition of Myocardial Infarction in Contemporary Randomized Clinical Trials
  • Embargo lift: 2:08 PM on Tuesday November 16, 2010

Return to top

Wednesday November 17, 2010

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

11:30 AM - 12:00 PM

  • Interviewee: Dr. Matthew Brennan
  • Trial: 1. Predictors of Bioprosthetic Aortic Valve Failure: Results in 73,616 Patients from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery National Database 2. Contemporary Risk of Follow-up Adverse Events in Older Patients with Chronic Kidney Disease and Dialysis Undergoing Percutaneous Coronary Interventions: A Report from the Merged NCDR CMS Registry
  • Embargo: 1.5:00 PM on Wednesday November 17, 2010 2. 5:00 PM on Monday November 15, 2010


12:00 PM

OPEN TIME SLOT

12:30 PM

12:30 PM - 1:00 PM

  • Interviewee: Dr. Robert Harrington
  • Topic: Duke Day in Review

Return to top